How the coronavirus copies its genetic material
Coronavirus Genome Replication
['FUNDING_R01'] · UNIV OF NORTH CAROLINA CHAPEL HILL · NIH-11397256
Scientists are working to understand how the coronavirus copies its genetic code so they can help create better antiviral medicines for people with COVID-19.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIV OF NORTH CAROLINA CHAPEL HILL (nih funded) |
| Locations | 1 site (CHAPEL HILL, UNITED STATES) |
| Trial ID | NIH-11397256 on ClinicalTrials.gov |
What this research studies
From your perspective, researchers will study the molecular machines the coronavirus uses to copy its RNA, focusing on the polymerase and the proofreading exonuclease called ExoN. They will use biochemical experiments and structural biology to observe enzyme activity and how antiviral molecules like remdesivir are incorporated or removed. The project uses purified viral proteins, reaction measurements, and advanced structural methods in the lab rather than enrolling patients. Results may reveal how drugs work or fail and guide the design of improved antiviral therapies.
Who could benefit from this research
Good fit: This grant supports laboratory research and is not enrolling patients for clinical participation or treatment.
Not a fit: People seeking immediate treatment options or clinical trial enrollment would not directly benefit from this laboratory-focused research.
Why it matters
Potential benefit: If successful, this work could point to more effective antiviral drugs that better stop SARS‑CoV‑2 from replicating.
How similar studies have performed: Previous structural and biochemical work has identified coronavirus replication proteins and informed drugs like remdesivir, but the detailed, quantitative mechanisms of drug action and exonuclease escape are not yet fully explained.
Where this research is happening
CHAPEL HILL, UNITED STATES
- UNIV OF NORTH CAROLINA CHAPEL HILL — CHAPEL HILL, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CAMERON, CRAIG E. — UNIV OF NORTH CAROLINA CHAPEL HILL
- Study coordinator: CAMERON, CRAIG E.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.